首頁 > 市場調查報告書 > 製藥

神經疾病

市場調查報告書

商品編碼

1808878

帕金森氏症深部腦部刺激市場（按產品、最終用途、國家和地區）—2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Deep Brain Stimulation In Parkinson's Disease Market, By Product, By End-use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年08月04日 | 出版商:

AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

帕金森氏症深部腦部刺激市場規模在 2024 年價值 9.1028 億美元，2025 年至 2032 年的複合年成長率為 10.30%。

帕金森氏症深部腦部刺激 (DBS) 市場是指專注於透過深部腦部刺激療法治療帕金森氏症的設備、技術和服務的全球性產業。 DBS 是透過手術將電極植入大腦特定區域，以發出受控的電脈衝，幫助控制藥物無法有效控制的運動症狀，例如震顫、僵硬和運動遲緩。該市場包括植入式脈衝產生器 (IPG)、電極、刺激編程軟體以及植入後支援服務。

帕金森氏症深部腦部刺激市場—市場動態

神經系統疾病盛行率上升推動市場成長

預計神經系統疾病的日益普及將在未來幾年推動帕金森氏症深部腦部刺激市場的發展。神經系統疾病是一類影響自主神經系統、周邊神經系統和中樞神經系統的疾病。深部腦部刺激系統用於神經外科手術，向目標區域傳遞電刺激，目的是改變或調節神經功能，達到可逆、可調節的治療效果。例如，美國國家組織帕金森基金會估計，2023 年 3 月美國將有近 9 萬人被診斷出患有帕金森氏症，比先前估計的每年 6 萬例診斷率增加 50%。因此，神經系統疾病的日益流行正在推動帕金森氏症深部腦部刺激市場的成長。

帕金森氏症市場的深部腦部刺激—關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 10.30%

根據產品細分，預計雙通道將在 2025 年佔據最大市場佔有率

根據最終用途細分，醫院是 2025 年的主要最終用途

按地區分類，北美是 2025 年的主要收入來源

帕金森氏症深部腦部刺激市場細分分析：

全球帕金森氏症深部腦部刺激市場根據產品、最終用途和地區進行細分。

市場依產品分為兩類：單通道和雙通道。雙通道細分市場將在2025年佔據最大佔有率，因為它在減少患者震顫和改善整體生活品質方面效果顯著。雙通道深部腦電刺激 (DBS) 設備在向特定腦區輸送電刺激方面控制力更強、精度更高，因此深受神經外科醫生和患者的歡迎。雙通道系統強大的性能和可靠性鞏固了其市場領先地位。

根據最終用途，市場分為四大類：醫院、門診手術中心、神經內科診所和研究中心。到2025年，醫院將佔據市場主導地位。醫院通常配備先進的醫療技術和專業人員，能夠為需要深部腦部電刺激（DBS）治療的患者提供全面的照護。許多患者更傾向於選擇醫院，因為手術較為複雜，並且需要在整個治療過程中持續監測和支持。此外，醫院通常提供多學科診療方案，包括神經科醫生、神經外科醫生和其他醫療保健專業人員，透過協調一致的護理來改善患者的治療效果。由於帕金森氏症通常表現為多種症狀，需要持續管理，因此醫院能夠提供有效治療所需的全面護理。

帕金森氏症深部腦部刺激市場—地理洞察

到2025年，北美深部腦部刺激（DBS）將在帕金森氏症市場佔據最大收益佔有率。該地區的主導地位可歸因於多種因素，包括帕金森氏症的高發病率、先進的醫療基礎設施以及政府和私人部門在研發方面的大量資金投入。機器人輔助植入和微電極設計的改進等技術進步推動了該地區市場的成長。

預計亞太地區帕金森氏症深部腦部刺激 (DBS) 市場將在預測期內實現最快成長。這一快速成長可歸因於帕金森氏症患者病率的上升、醫療保健成本的上漲以及人們對 DBS 治療的認知的提高。該地區也受益於技術進步和新型 DBS 設備的引入。亞太地區各國政府正積極鼓勵 DBS 療法的應用，並提供優惠政策和研發資金。

帕金森氏症深部腦部刺激市場—競爭格局：

幾家大型醫療器材公司透過研發推動DBS市場的創新和市場成長。領先的企業不斷改進產品，並透過先進的技術和以患者為中心的解決方案脫穎而出。幾家主要企業主導市場，市場整合度適中。然而，新公司和新創公司正在加劇競爭和技術進步，從而改善DBS系統和患者治療效果。美敦力、波士頓科學和雅培是DBS市場的領導者，擁有豐富的神經刺激設備產品組合和全球影響力。美敦力是最大的DBS製造商之一，提供具有自適應刺激和MRI相容性的系統。創新以及與研究機構的合作使該公司保持了競爭力。另一家主要企業波士頓科學則致力於開發尖端的DBS治療技術，以滿足不同患者的需求。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美帕金森氏症深部腦部刺激主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模及預測（按產品）
- 北美市場規模及預測（依最終用途）
- 美國
- 加拿大
歐洲
- 概述
- 帕金森氏症深部腦部刺激歐洲主要製造商
- 歐洲市場規模及預測（按國家/地區）
- 歐洲市場規模及預測（按產品）
- 歐洲市場規模及預測（依最終用途）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區帕金森氏症深部腦部刺激主要製造商
- 亞太地區市場規模及預測（依國家）
- 亞太地區市場規模及預測（依產品）
- 亞太地區市場規模及預測（依最終用途）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲（LATAM）
- 概述
- 帕金森氏症深部腦部刺激拉丁美洲主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（按產品）
- 拉丁美洲市場規模及預測（依最終用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲（MEA）
- 概述
- 帕金森氏症深部腦部刺激的主要製造商在中東和非洲
- MEA 市場規模及預測（依國家/地區）
- MEA 市場規模及預測（依產品）
- MEA 市場規模及預測（依最終用途）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其餘地區

第10章：帕金森氏症產業深部腦部刺激關鍵供應商分析

競爭基準化分析
- Competitive Dashboard
- Competitive Positioning
公司簡介
- Abbott
- Boston Scientific Corporation
- Medtronic
- Others

第 11 章：360 度分析師視角

第 12 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV5511

Deep Brain Stimulation In Parkinson's Disease Market size was valued at US$ 910.28 Million in 2024, expanding at a CAGR of 10.30% from 2025 to 2032.

Deep Brain Stimulation (DBS) in Parkinson's Disease market refers to the global industry that focuses on devices, technologies, and services for treating Parkinson's disease with deep brain stimulation therapy. DBS is the surgical implantation of electrodes in specific areas of the brain to deliver controlled electrical impulses, which help manage motor symptoms such as tremors, stiffness, and bradykinesia that are not adequately controlled by medication. This market consists of implantable pulse generators (IPGs), electrodes, stimulation programming software, and post-implantation support services.

Deep Brain Stimulation In Parkinson's Disease Market- Market Dynamics

Rising prevalence of neurological disorders fuels market growth

The growing prevalence of neurological disorders is expected to drive the Deep Brain Stimulation In Parkinson's Disease Market in the coming years. Neurological disorders are a diverse group of diseases that affect the autonomic, peripheral, and central nervous systems. Deep brain stimulation systems are used in neurosurgical procedures to deliver electrical stimulation to the target area, with the goal of altering or modulating neural functioning and achieving a reversible, adjustable, and therapeutic effect. For instance, the Parkinson's Foundation, a US-based national organization, estimates that nearly 90,000 people were diagnosed with Parkinson's disease in the United States in March 2023, a 50% increase from the previously estimated rate of 60,000 diagnoses per year. As a result, the growing prevalence of neurological disorders is driving the growth of the Deep Brain Stimulation in Parkinson's Disease market.

Deep Brain Stimulation In Parkinson's Disease Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.30% over the forecast period (2025-2032)

Based on Product segmentation, Dual-channel is predicted to show maximum market share in the year 2025

Based on End-use segmentation, hospital is the leading End-use in 2025

On the basis of region, North America is the leading revenue generator in 2025

Deep Brain Stimulation In Parkinson's Disease Market- Segmentation Analysis:

The Global Deep Brain Stimulation In Parkinson's Disease Market is segmented on the basis of Product, End-use, and Region.

The market is divided into two categories based on Product: Single-channel, and Dual-channel. The dual-channel segment will account for the largest share in 2025 due to its superior effectiveness in reducing patient tremors and improving overall quality of life. Dual-channel DBS devices provide greater control and precision in delivering electrical stimulation to specific brain regions, making them popular among neurosurgeons and patients alike. Dual-channel systems' robust performance and reliability have cemented their market leadership.

The market is divided into four categories based on End-use: Hospitals, Ambulatory Surgical Centers, Neurology Clinics, and Research Centers. The hospital segment will dominate the market in 2025. Hospitals are frequently equipped with advanced medical technology and specialized personnel, allowing them to provide comprehensive care to patients requiring DBS therapy. Many patients prefer hospitals because of the procedure's complexity and the need for continuous monitoring and support throughout the treatment process. Furthermore, hospitals typically provide a multidisciplinary approach that includes neurologists, neurosurgeons, and other healthcare professionals, improving patient outcomes through coordinated care. Because Parkinson's disease frequently presents with a variety of symptoms that necessitate ongoing management, hospitals are well-positioned to provide the comprehensive care required for effective treatment.

Deep Brain Stimulation In Parkinson's Disease Market- Geographical Insights

North America Deep Brain Stimulation will have the largest revenue share in the Parkinson's disease market in 2025. The region's dominance can be attributed to a variety of factors, including a high prevalence of Parkinson's disease, advanced healthcare infrastructure, and substantial government and private funding for research and development. Technological advancements, such as robot-assisted implantation and improved microelectrode designs, have boosted market growth in this region.

The Asia Pacific Deep Brain Stimulation In Parkinson's Disease Market is expected to grow the fastest over the forecast period. This rapid growth can be attributed to the rising prevalence of Parkinson's disease, rising healthcare costs, and increased awareness of DBS treatment. The region is also benefiting from technological advancements and the introduction of new DBS devices. Governments in the Asia Pacific region are actively encouraging the use of DBS therapy by providing favorable policies and funding for R&D.

Deep Brain Stimulation In Parkinson's Disease Market- Competitive Landscape:

Several major medical device companies drive innovation and market growth in the DBS market through research and development. Leading players improve their products and differentiate themselves with advanced technologies and patient-centric solutions. Several major players dominate the market, which is moderately consolidated. However, new companies and startups are increasing competition and technological advancements, improving DBS systems and patient outcomes. Medtronic, Boston Scientific, and Abbott are DBS market leaders with extensive neurostimulation device portfolios and global presence. One of the largest DBS manufacturers, Medtronic, offers systems with adaptive stimulation and MRI compatibility. Innovation and collaboration with research institutions have kept the company competitive. Boston Scientific, another major player, develops cutting-edge DBS therapy technologies to meet diverse patient needs.

Recent Developments:

In August 2024, Medtronic plc has received FDA approval for Asleep DBS surgery for Parkinson's and essential tremor patients. This novel approach allows patients to have DBS surgery while awake or asleep, increasing flexibility and comfort.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott
Boston Scientific Corporation
Medtronic
Others

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Single-channel
Dual-channel

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centers
Neurology Clinics
Research Centers

GLOBAL DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Deep Brain Stimulation In Parkinson's Disease Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Product
- 2.1.2. Deep Brain Stimulation In Parkinson's Disease Market Snippet by End-use
- 2.1.3. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Country
- 2.1.4. Deep Brain Stimulation In Parkinson's Disease Market Snippet by Region
2.2. Competitive Insights

3. Deep Brain Stimulation In Parkinson's Disease Key Market Trends

3.1. Deep Brain Stimulation In Parkinson's Disease Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Deep Brain Stimulation In Parkinson's Disease Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Deep Brain Stimulation In Parkinson's Disease Market Opportunities
3.4. Deep Brain Stimulation In Parkinson's Disease Market Future Trends

4. Deep Brain Stimulation In Parkinson's Disease Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Deep Brain Stimulation In Parkinson's Disease Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Deep Brain Stimulation In Parkinson's Disease Market Landscape

6.1. Deep Brain Stimulation In Parkinson's Disease Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Deep Brain Stimulation In Parkinson's Disease Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Single-channel
- 7.1.3. Dual-channel

8. Deep Brain Stimulation In Parkinson's Disease Market - By End-use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End-use, 2024 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Ambulatory Surgical Centers
- 8.1.4. Neurology Clinics
- 8.1.5. Research Centers

9. Deep Brain Stimulation In Parkinson's Disease Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.7. UK
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.7.4. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.8. France
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.8.4. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.9. Italy
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.9.4. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.10. Spain
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.10.4. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.11. The Netherlands
  - 9.3.11.1. Overview
  - 9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.11.4. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
  - 9.3.12.1. Overview
  - 9.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.12.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.13. Russia
  - 9.3.13.1. Overview
  - 9.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.13.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Overview
  - 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Asia Pacific
- 9.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.5. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.6. China
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.6.4. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.7. India
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.7.4. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.8.4. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.9.4. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.11. Indonesia
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.12. Thailand
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.5. Latin America (LATAM)
- 9.5.1. Overview
- 9.5.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Latin America
- 9.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.5. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa (MEA)
- 9.6.1. Overview
- 9.6.2. Deep Brain Stimulation In Parkinson's Disease Key Manufacturers in Middle East and Africa
- 9.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.5. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.7. UAE
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.7.4. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Deep Brain Stimulation In Parkinson's Disease Industry

10.1. Competitive Benchmarking
- 10.1.1. Competitive Dashboard
- 10.1.2. Competitive Positioning
10.2. Company Profiles
- 10.2.1. Abbott
- 10.2.2. Boston Scientific Corporation
- 10.2.3. Medtronic
- 10.2.4. Others